Phase 1 study of APTO-253 HCl, an inducer of KLF4, in patients with advanced or metastatic solid tumors
Crossref DOI link: https://doi.org/10.1007/s10637-015-0273-z
Published Online: 2015-08-14
Published Print: 2015-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cercek, Andrea
Wheler, Jennifer
Murray, Peter E.
Zhou, Shawn
Saltz, Leonard
Text and Data Mining valid from 2015-08-14
Version of Record valid from 2015-08-14
Article History
Received: 5 June 2015
Accepted: 7 July 2015
First Online: 14 August 2015